{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T23:32:07Z","timestamp":1769815927991,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Health Research Board","award":["Health Research Award HRA_POR\/2012\/18"],"award-info":[{"award-number":["Health Research Award HRA_POR\/2012\/18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Microenvironment"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12307-019-00220-6","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T14:47:46Z","timestamp":1551710866000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Altered T Cell Migratory Capacity in the Progression from Barrett Oesophagus to Oesophageal Adenocarcinoma"],"prefix":"10.1007","volume":"12","author":[{"given":"Maria E.","family":"Kavanagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa J.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh T.","family":"Gilmartin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Feighery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finbar","family":"MacCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dermot","family":"O\u2019Toole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayanasamy","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacintha","family":"O\u2019 Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3363-3763","authenticated-orcid":false,"given":"Joanne","family":"Lysaght","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"issue":"8","key":"220_CR1","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N et al (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101(8):1900\u20131920 quiz 1943","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"220_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.bpg.2008.02.001","volume":"22","author":"O Anand","year":"2008","unstructured":"Anand O, Wani S, Sharma P (2008) When and how to grade Barrett's columnar metaplasia: the Prague system. Best Pract Res Clin Gastroenterol 22(4):661\u2013669","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"8","key":"220_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/gut.2003.028076","volume":"53","author":"M Solaymani-Dodaran","year":"2004","unstructured":"Solaymani-Dodaran M et al (2004) Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 53(8):1070\u20131074","journal-title":"Gut"},{"issue":"1","key":"220_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2015.10.019","volume":"370","author":"ME Kavanagh","year":"2016","unstructured":"Kavanagh ME, Conroy MJ, Clarke NE, Gilmartin NT, O'Sullivan KE, Feighery R, MacCarthy F, O'Toole D, Ravi N, Reynolds JV, O'Sullivan J, Lysaght J (2016) Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma. Cancer Lett 370(1):117\u2013124","journal-title":"Cancer Lett"},{"issue":"8","key":"220_CR5","doi-asserted-by":"publisher","first-page":"G641","DOI":"10.1152\/ajpgi.00386.2013","volume":"306","author":"J Shan","year":"2014","unstructured":"Shan J, Oshima T, Farre R, Fukui H, Watari J, Miwa H (2014) IL-4 induces columnar-like differentiation of esophageal squamous epithelium through JAK\/PI3K pathway: possible role in pathogenesis of Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol 306(8):G641\u2013G649","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"220_CR6","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/ijc.21598","volume":"118","author":"T Sakamoto","year":"2006","unstructured":"Sakamoto T, Saito H, Tatebe S, Tsujitani S, Ozaki M, Ito H, Ikeguchi M (2006) Interleukin-10 expression significantly correlates with minor CD8+ T-cell infiltration and high microvessel density in patients with gastric cancer. Int J Cancer 118(8):1909\u20131914","journal-title":"Int J Cancer"},{"issue":"7","key":"220_CR7","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/bjs.7498","volume":"98","author":"J Lysaght","year":"2011","unstructured":"Lysaght J, Allott EH, Donohoe CL, Howard JM, Pidgeon GP, Reynolds JV (2011) T lymphocyte activation in visceral adipose tissue of patients with oesophageal adenocarcinoma. Br J Surg 98(7):964\u2013974","journal-title":"Br J Surg"},{"issue":"6","key":"220_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/icb.2016.26","volume":"94","author":"MJ Conroy","year":"2016","unstructured":"Conroy MJ, Galvin KC, Kavanagh ME, Mongan AM, Doyle SL, Gilmartin N, O'Farrelly C, Reynolds JV, Lysaght J (2016) CCR1 antagonism attenuates T cell trafficking to omentum and liver in obesity-associated cancer. Immunol Cell Biol 94(6):531\u2013537","journal-title":"Immunol Cell Biol"},{"key":"220_CR9","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3389\/fimmu.2018.01867","volume":"9","author":"MJ Conroy","year":"2018","unstructured":"Conroy MJ, Maher SG, Melo AM, Doyle SL, Foley E, Reynolds JV, Long A, Lysaght J (2018) Identifying a novel role for Fractalkine (CX3CL1) in memory CD8(+) T cell accumulation in the Omentum of obesity-associated Cancer patients. Front Immunol 9:1867","journal-title":"Front Immunol"},{"issue":"5","key":"220_CR10","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","volume":"16","author":"T Ishii","year":"2010","unstructured":"Ishii T, Ishida T, Utsunomiya A, Inagaki A, Yano H, Komatsu H, Iida S, Imada K, Uchiyama T, Akinaga S, Shitara K, Ueda R (2010) Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma. Clin Cancer Res 16(5):1520\u20131531","journal-title":"Clin Cancer Res"},{"issue":"22","key":"220_CR11","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-04-0983","volume":"10","author":"T Ishida","year":"2004","unstructured":"Ishida T et al (2004) The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia\/lymphoma. Clin Cancer Res 10(22):7529\u20137539","journal-title":"Clin Cancer Res"},{"issue":"3","key":"220_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1572-0241.2003.07303.x","volume":"98","author":"H Isomoto","year":"2003","unstructured":"Isomoto H, Wang A, Mizuta Y, Akazawa Y, Ohba K, Omagari K, Miyazaki M, Murase K, Hayashi T, Inoue K, Murata I, Kohno S (2003) Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 98(3):551\u2013556","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"220_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.187.6.875","volume":"187","author":"F Sallusto","year":"1998","unstructured":"Sallusto F, Lenig D, Mackay CR, Lanzavecchia A (1998) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187(6):875\u2013883","journal-title":"J Exp Med"},{"issue":"12","key":"220_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0167-5699(98)01346-2","volume":"19","author":"F Sallusto","year":"1998","unstructured":"Sallusto F, Lanzavecchia A, Mackay CR (1998) Chemokines and chemokine receptors in T-cell priming and Th1\/Th2-mediated responses. Immunol Today 19(12):568\u2013574","journal-title":"Immunol Today"},{"issue":"12","key":"220_CR15","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","volume":"99","author":"BF Skinnider","year":"2002","unstructured":"Skinnider BF, Mak TW (2002) The role of cytokines in classical Hodgkin lymphoma. Blood 99(12):4283\u20134297","journal-title":"Blood"},{"issue":"11","key":"220_CR16","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1182\/blood.V92.11.4036","volume":"92","author":"S Sozzani","year":"1998","unstructured":"Sozzani S et al (1998) The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92(11):4036\u20134039","journal-title":"Blood"},{"issue":"7","key":"220_CR17","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/j.1349-7006.2011.01934.x","volume":"102","author":"YM Yang","year":"2011","unstructured":"Yang YM, Feng AL, Zhou CJ, Liang XH, Mao HT, Deng BP, Yan S, Sun JT, du LT, Liu J, Wang QJ, Neckenig MR, Yang QF, Qu X (2011) Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppression. Cancer Sci 102(7):1264\u20131271","journal-title":"Cancer Sci"},{"issue":"4","key":"220_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s12032-014-0882-y","volume":"31","author":"Q Liu","year":"2014","unstructured":"Liu Q, Rexiati M, Yang Y, Wang WG, Azhati B, SaiMaiti W, Wang YJ (2014) Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma. Med Oncol 31(4):882","journal-title":"Med Oncol"},{"key":"220_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000323299","volume":"41","author":"K Yamanaka","year":"2011","unstructured":"Yamanaka K, Mizutani H (2011) The role of cytokines\/chemokines in the pathogenesis of atopic dermatitis. Curr Probl Dermatol 41:80\u201392","journal-title":"Curr Probl Dermatol"},{"issue":"5","key":"220_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1517\/17460441.2014.897324","volume":"9","author":"JE Pease","year":"2014","unstructured":"Pease JE, Horuk R (2014) Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4. Expert Opin Drug Discovery 9(5):467\u2013483","journal-title":"Expert Opin Drug Discovery"},{"issue":"Pt B","key":"220_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejphar.2015.05.018","volume":"763","author":"R Solari","year":"2015","unstructured":"Solari R, Pease JE (2015) Targeting chemokine receptors in disease--a case study of CCR4. Eur J Pharmacol 763(Pt B):169\u2013177","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"220_CR22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1248\/bpb.33.1067","volume":"33","author":"Y Nakagami","year":"2010","unstructured":"Nakagami Y, Kawase Y, Yonekubo K, Nosaka E, Etori M, Takahashi S, Takagi N, Fukuda T, Kuribayashi T, Nara F, Yamashita M (2010) RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in Guinea pigs. Biol Pharm Bull 33(6):1067\u20131069","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"220_CR23","doi-asserted-by":"publisher","first-page":"e101137","DOI":"10.1371\/journal.pone.0101137","volume":"9","author":"J Liu","year":"2014","unstructured":"Liu J et al (2014) CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo. PLoS One 9(6):e101137","journal-title":"PLoS One"},{"issue":"2","key":"220_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3748\/wjg.v22.i2.833","volume":"22","author":"VO Frick","year":"2016","unstructured":"Frick VO et al (2016) Chemokine\/chemokine receptor pair CCL20\/CCR6 in human colorectal malignancy: an overview. World J Gastroenterol 22(2):833\u2013841","journal-title":"World J Gastroenterol"},{"issue":"12","key":"220_CR25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/bjc.2016.113","volume":"114","author":"N Kapur","year":"2016","unstructured":"Kapur N, Mir H, Clark III CE, Krishnamurti U, Beech DJ, Lillard JW, Singh S (2016) CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition. Br J Cancer 114(12):1343\u20131351","journal-title":"Br J Cancer"},{"issue":"8","key":"220_CR26","doi-asserted-by":"publisher","first-page":"e1189052","DOI":"10.1080\/2162402X.2016.1189052","volume":"5","author":"B Nandi","year":"2016","unstructured":"Nandi B et al (2016) Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages. Oncoimmunology 5(8):e1189052","journal-title":"Oncoimmunology"},{"issue":"8","key":"220_CR27","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1182\/blood-2003-01-0007","volume":"102","author":"A Meissner","year":"2003","unstructured":"Meissner A et al (2003) CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress. Blood 102(8):2724\u20132727","journal-title":"Blood"},{"issue":"52","key":"220_CR28","doi-asserted-by":"publisher","first-page":"89998","DOI":"10.18632\/oncotarget.21286","volume":"8","author":"L Kistner","year":"2017","unstructured":"Kistner L et al (2017) Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer. Oncotarget 8(52):89998\u201390012","journal-title":"Oncotarget"},{"issue":"5","key":"220_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"JR Groom","year":"2011","unstructured":"Groom JR, Luster AD (2011) CXCR3 in T cell function. Exp Cell Res 317(5):620\u2013631","journal-title":"Exp Cell Res"},{"issue":"25","key":"220_CR30","doi-asserted-by":"publisher","first-page":"13812","DOI":"10.1073\/pnas.240469997","volume":"97","author":"F Cocchi","year":"2000","unstructured":"Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA, Garzino-Demo A, Colombini-Hatch S, Margolis D, Gallo RC (2000) Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. Proc Natl Acad Sci U S A 97(25):13812\u201313817","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5243","key":"220_CR31","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","volume":"270","author":"F Cocchi","year":"1995","unstructured":"Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270(5243):1811\u20131815","journal-title":"Science"}],"container-title":["Cancer Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12307-019-00220-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12307-019-00220-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12307-019-00220-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:15:19Z","timestamp":1583176519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12307-019-00220-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1007\/s12307-019-00220-6","relation":{},"ISSN":["1875-2292","1875-2284"],"issn-type":[{"value":"1875-2292","type":"print"},{"value":"1875-2284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"20 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The study received ethical approval from the St James\u2019s Hospital Ethics Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}